健康之路发布中期业绩，股东应占溢利706.6万元

Core Viewpoint - The company reported a decline in revenue for the first half of 2025, but achieved a profit for shareholders, contrasting with a loss in the previous year [1] Financial Performance - Revenue for the first half of 2025 was 518 million RMB, representing a year-on-year decrease of 15.3% [1] - The profit attributable to equity shareholders was 7.066 million RMB, compared to a loss of 55.818 million RMB in the same period last year [1] - Basic earnings per share were reported at 0.01 RMB [1]